Chiron Corp. says Wednesday it expects to provide a vaccine for the 2005-2006 flu season after a recent favorable inspection of the plant by U.S. regulators.

The company postponed U.S. sales of its flu vaccine last year due to contamination problems at its plant in England, which led to the withdrawal of its manufacturing license for Fluvirin last October

The Food and Drug Administration is considering the use of leeches and maggots in more medical procedures.

Lisa Darmo, of Carolina Biological Supply in Burlington, says special leeches for medical use only are imported from England and shipped to hospitals across the country

Chiron Corp. says on Wednesday that it expects to provide a vaccine for the 2005-2006 flu season after a recent favorable inspection of the plant by U.S. regulators, reports Reuters

The company had to postpone U.S. sales of its flu vaccine last year due to contamination problems at its plant in England, which led to the withdrawal of its manufacturing license for Fluvirin last October

Takeda Pharmaceutical Co. announces Tuesday approval from the U.S. Food and Drug Administration for its new diabetes drug.

Actoplus Met is a single tablet that merges Takeda's two existing diabetes drugs, Actos and Metformin. Takeda Pharmaceuticals North America Inc. will sell the tablet in the United States starting in October

Takeda Pharmaceutical Co. announces on Tuesday that it has obtained consent from the U.S. Food and Drug Administration for its new diabetes drug, reports The Associated Press.

Actoplus Met is a single tablet that merges Takeda's two existing diabetes drugs, Actos and Metformin. Takeda Pharmaceuticals North America Inc. will sell the tablet in the United States starting in October